Page last updated: 2024-10-19

melatonin and Goldblatt Syndrome

melatonin has been researched along with Goldblatt Syndrome in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Melatonin treatment effectively reduced baseline MAP and sympathoexcitation to the ischemic kidney in renovascular hypertensive rats."1.51Melatonin attenuates renal sympathetic overactivity and reactive oxygen species in the brain in neurogenic hypertension. ( Almeida, VR; Amaral, FG; Bergamaschi, CT; Campos, RR; Cespedes, JG; Futuro-Neto, HA; Nishi, EE; Pontes, RB; Simon, KA, 2019)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Simko, F1
Reiter, RJ1
Paulis, L1
Nishi, EE1
Almeida, VR1
Amaral, FG1
Simon, KA1
Futuro-Neto, HA1
Pontes, RB1
Cespedes, JG1
Campos, RR1
Bergamaschi, CT1
Erşahin, M1
Sehirli, O1
Toklu, HZ1
Süleymanoglu, S1
Emekli-Alturfan, E1
Yarat, A1
Tatlidede, E1
Yeğen, BC1
Sener, G1

Other Studies

3 other studies available for melatonin and Goldblatt Syndrome

ArticleYear
Melatonin as a rational alternative in the conservative treatment of resistant hypertension.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2019, Volume: 42, Issue:11

    Topics: Animals; Blood Pressure; Brain; Conservative Treatment; Denervation; Hypertension; Hypertension, Ren

2019
Melatonin attenuates renal sympathetic overactivity and reactive oxygen species in the brain in neurogenic hypertension.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2019, Volume: 42, Issue:11

    Topics: Animals; Antioxidants; Baroreflex; Blood Pressure; Brain Stem; Drug Evaluation, Preclinical; Hyperte

2019
Melatonin improves cardiovascular function and ameliorates renal, cardiac and cerebral damage in rats with renovascular hypertension.
    Journal of pineal research, 2009, Volume: 47, Issue:1

    Topics: Analysis of Variance; Angiotensin II; Animals; Blood Pressure; Brain; Cardiovascular Physiological P

2009